1.
Progress of lymphocyte activation gene 3 and programmed cell death protein 1 antibodies for cancer treatment: A review. Biomol Biomed [Internet]. 2024 Apr. 6 [cited 2024 Jun. 26];:731–741. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/10339